|
38 Companies |
|
50 Products |
|
50 Products |
|
51 Mechanisms of Action |
|
3 Trials |
|
1810 News |
|
| «12...20212223242526272829303132» |
- Enrollment change: Tumor Markers in Lung Cancer: DCAMLK-1LK-1 (clinicaltrials.gov) - Aug 7, 2012
P=N/A, N=49, Completed, Sponsor: University of Oklahoma
N=40 --> 49
- Trial completion: Tumor Markers in Lung Cancer: DCAMLK-1LK-1 (clinicaltrials.gov) - Aug 7, 2012
P=N/A, N=49, Completed, Sponsor: University of Oklahoma
N=40 --> 49 Recruiting --> Completed
- | Chantix (varenicline) / Pfizer
Trial completion: STOP: Smoking Termination Opportunity for inPatients (clinicaltrials.gov) - Aug 6, 2012
P2/3, N=392, Completed, Sponsor: The Queen Elizabeth Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- lisdexamfetamine / Generic mfg.
Trial completion: Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study (clinicaltrials.gov) - Aug 6, 2012
P=N/A, N=32, Completed, Sponsor: Duke University
Active, not recruiting --> Completed Recruiting --> Completed
- | Enrollment closed: BCBSM-OE: Tobacco Tactics Website for Operating Engineers (clinicaltrials.gov) - Aug 5, 2012
P3, N=100, Active, not recruiting, Sponsor: University of Michigan
Recruiting --> Completed Recruiting --> Active, not recruiting
- | New P1 trial: Nicotine Patch - Multidose Bioequivalence Study (clinicaltrials.gov) - Aug 2, 2012
P1, N=43, Completed, Sponsor: Pierre Fabre Medicament
- | New P1 trial: Nicotine Patch Bioequivalence Study (clinicaltrials.gov) - Aug 2, 2012
P1, N=28, Completed, Sponsor: Pierre Fabre Medicament
- Trial completion: Woodsmoke Exposure and Cardiovascular Function (clinicaltrials.gov) - Aug 2, 2012
P=N/A, N=20, Completed, Sponsor: University of Edinburgh
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment change: Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=63, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed N=120 --> 63
- Enrollment closed: Pilot Study of Patient Navigation to Promote Smoking Cessation (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=240, Active, not recruiting, Sponsor: Boston University
N=120 --> 63 Enrolling by invitation --> Active, not recruiting
- Trial completion: Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=63, Completed, Sponsor: University of Pennsylvania
Enrolling by invitation --> Active, not recruiting Active, not recruiting --> Completed
- ||||| New P2 trial: Nicotine Patch Safety Study (clinicaltrials.gov) - Jul 30, 2012
P2, N=160, Completed, Sponsor: Pierre Fabre Medicament
- Trial completion: Effects of Nicotine on Areas of Impaired and Preserved Functioning in Schizophrenia (clinicaltrials.gov) - Jul 30, 2012
P=N/A, N=120, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Behavioral Exercise Intervention for Smoking Cessation (clinicaltrials.gov) - Jul 30, 2012
P2, N=61, Completed, Sponsor: Butler Hospital
Recruiting --> Completed Active, not recruiting --> Completed
- Clinical: Acceptance and Commitment Therapy for Smoking Cessation in the Primary Care Setting (clinicaltrials.gov) - Jul 25, 2012
P=N/A, N=156, Recruiting, Sponsor: The Hong Kong Polytechnic University
- Enrollment closed: NICU Asthma Education and Secondhand Smoke Reduction Study (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=165, Active, not recruiting, Sponsor: University of Rochester
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- prazosin / Generic mfg.
New P2 trial: Prazosin for Smoking Cessation (clinicaltrials.gov) - Jul 15, 2012
P2, N=1, Terminated, Sponsor: Centre for Addiction and Mental Health
- ||| Chantix (varenicline) / Pfizer
Trial completion: Denic: De-nicotinised Cigarettes Study (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=200, Completed, Sponsor: Queen Mary University of London
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial initiation date: Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=60, Recruiting, Sponsor: HealthPartners Institute for Education and Research
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Jul 2012
- ||||| Chantix (varenicline) / Pfizer
New P4 trial: ChanLight: Varenicline for Light Smokers (clinicaltrials.gov) - Jul 10, 2012
P4, N=224, Recruiting, Sponsor: Mayo Clinic
- | New P4 trial: TC5Redes: Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months (clinicaltrials.gov) - Jul 10, 2012
P4, N=10000, Recruiting, Sponsor: University of California, San Francisco
- |||| Chantix (varenicline) / Pfizer
Trial completion: Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression (clinicaltrials.gov) - Jul 10, 2012
P4, N=525, Completed, Sponsor: Pfizer
Initiation date: Nov 2011 --> Jul 2012 Active, not recruiting --> Completed
- Enrollment open: Social Determinants and Smoking Cessation (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=320, Recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Examining the Effect of the Nicotine Patch in Male and Female Smokers - 3 (clinicaltrials.gov) - Jul 5, 2012
P=N/A, N=80, Completed, Sponsor: Virginia Commonwealth University
Not yet recruiting --> Recruiting N=100 --> 80
- | Trial completion: Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations (clinicaltrials.gov) - Jul 5, 2012
P1, N=13, Completed, Sponsor: Pierre Fabre Medicament
N=100 --> 80 Recruiting --> Completed
- Clinical: ProjFreshAir: Improving Household Air Quality in Homes With Children (clinicaltrials.gov) - Jul 4, 2012
P=N/A, N=300, Recruiting, Sponsor: San Diego State University
- New P2 trial: Acute Effects of Exercise in Smokers With Schizophrenia (clinicaltrials.gov) - Jul 4, 2012
P2, N=32, Recruiting, Sponsor: Brown University
- Chantix (varenicline) / Pfizer
Enrollment closed: The Effect of Naltrexone and Varenicline on Alcohol-Mediated Smoking Lapse (clinicaltrials.gov) - Jul 4, 2012
P2, N=60, Active, not recruiting, Sponsor: Yale University
Recruiting --> Completed Recruiting --> Active, not recruiting
- Chantix (varenicline) / Pfizer
Enrollment closed: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior (clinicaltrials.gov) - Jul 4, 2012
P2, N=60, Active, not recruiting, Sponsor: Yale University
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Clinical: Culturally Targeted & Individually Tailored Smoking Cessation Study: LGBT Smokers (clinicaltrials.gov) - Jul 2, 2012
P=N/A, N=400, Recruiting, Sponsor: University of Illinois at Chicago
- | Trial completion: Testing Counseling Styles to Motivate Smokers to Quit (clinicaltrials.gov) - Jul 2, 2012
P3, N=255, Completed, Sponsor: University of Missouri, Kansas City
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| Chantix (varenicline) / Pfizer
Enrollment open: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (clinicaltrials.gov) - Jun 28, 2012
P4, N=8000, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- topiramate / Generic mfg.
Enrollment open: Topiramate to Aid Smoking Cessation in Alcohol Dependent Men (clinicaltrials.gov) - Jun 28, 2012
P2, N=150, Recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- Trial completion, Metastases: 007/055/OMI: K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications (clinicaltrials.gov) - Jun 26, 2012
P=N/A, N=150, Completed, Sponsor: National Institute of Cancerolog
Active, not recruiting --> Recruiting Recruiting --> Completed
- | Enrollment change: Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers (clinicaltrials.gov) - Jun 24, 2012
P2/3, N=363, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed N=600 --> 363
- | Enrollment change: Smoking Treatment in HIV Clinical Care Settings (clinicaltrials.gov) - Jun 24, 2012
P3, N=207, Completed, Sponsor: University of California, San Francisco
N=600 --> 363 N=280 --> 207
- | Enrollment change: LGBT Internet Based Smoking Treatment - 1 (clinicaltrials.gov) - Jun 24, 2012
P3, N=792, Completed, Sponsor: University of California, San Francisco
N=280 --> 207 N=600 --> 792
- Trial completion: A Virtual Arm to Stop Smoking (clinicaltrials.gov) - Jun 24, 2012
P=N/A, N=91, Completed, Sponsor: Universite du Quebec en Outaouais
N=600 --> 792 Active, not recruiting --> Completed
- | Trial completion: Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers (clinicaltrials.gov) - Jun 24, 2012
P2/3, N=363, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Smoking Treatment in HIV Clinical Care Settings (clinicaltrials.gov) - Jun 24, 2012
P3, N=207, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: LGBT Internet Based Smoking Treatment - 1 (clinicaltrials.gov) - Jun 24, 2012
P3, N=792, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- New P1 trial: TCapp-1: San Francisco Stop Smoking App - Pilot Study (clinicaltrials.gov) - Jun 20, 2012
P1, N=12000, Recruiting, Sponsor: University of California, San Francisco
- New P2 trial: AAT-1: Tobacco Approach Avoidance Training for Adolescent Smokers-1 (clinicaltrials.gov) - Jun 19, 2012
P2, N=40, Completed, Sponsor: Yale University
- | New P2 trial: AAT-2: Tobacco Approach Avoidance Training for Adolescent Smokers-2 (clinicaltrials.gov) - Jun 19, 2012
P2, N=66, Completed, Sponsor: Yale University
- | Chantix (varenicline) / Pfizer
New P4 trial, Real-world evidence, Real-world: Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (clinicaltrials.gov) - Jun 18, 2012
P4, N=1068, Active, not recruiting, Sponsor: University of Ottawa Heart Institute
- | bupropion / Generic mfg.
New P4 trial, Combination therapy: Bupropion Alone or Combined With Nicotine Gum (clinicaltrials.gov) - Jun 13, 2012
P4, N=608, Completed, Sponsor: University of Wisconsin, Madison
- bupropion sustained-release / Generic mfg.
New P4 trial: Bupropion SR Plus Counseling for Smoking Cessation (clinicaltrials.gov) - Jun 13, 2012
P4, N=0, Completed, Sponsor: University of Wisconsin, Madison
- ||||| New P4 trial: Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study (clinicaltrials.gov) - Jun 13, 2012
P4, N=60, Recruiting, Sponsor: Universit
- Chantix (varenicline) / Pfizer
Enrollment change: START: Menominee Stop Tobacco Abuse Renew Tradition Study (clinicaltrials.gov) - Jun 11, 2012
P=N/A, N=108, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed N=150 --> 108
- Chantix (varenicline) / Pfizer
Trial completion: START: Menominee Stop Tobacco Abuse Renew Tradition Study (clinicaltrials.gov) - Jun 11, 2012
P=N/A, N=108, Completed, Sponsor: University of Wisconsin, Madison
N=150 --> 108 Recruiting --> Completed